Give the nurses and pharmacists who take patients' calls a tool that walks them through recognising and managing side effects of modern cancer drugs, including when to escalate.
Immunotherapy and targeted therapy toxicities are managed by triage nurses and pharmacists who may see a given drug rarely. Guideline-based toxicity algorithms (ESMO, ASCO, SITC) exist as tables. Encoding them as decision support integrated with ePRO alerts, with drug-specific pathways and escalation triggers, would standardise management and shorten time to steroids or hospital review for serious immune-related events.
Shares The answer is 17 years, what is the question: understanding time lags in translational research, Not enough oncologists, nurses, pathologists, physicists, Knowledge reaches practice too slowly.
Shares The answer is 17 years, what is the question: understanding time lags in translational research, Knowledge reaches practice too slowly.
Shares The answer is 17 years, what is the question: understanding time lags in translational research, Knowledge reaches practice too slowly.
Shares The answer is 17 years, what is the question: understanding time lags in translational research, Knowledge reaches practice too slowly.
Shares The answer is 17 years, what is the question: understanding time lags in translational research, Knowledge reaches practice too slowly.
Shares Not enough oncologists, nurses, pathologists, physicists, Knowledge reaches practice too slowly.
Shares The answer is 17 years, what is the question: understanding time lags in translational research, Knowledge reaches practice too slowly.
Shares The answer is 17 years, what is the question: understanding time lags in translational research, Knowledge reaches practice too slowly.